相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
Chadwick W. Christine et al.
ANNALS OF NEUROLOGY (2019)
On the Role of Aminochrome in Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Parkinson's Disease
Juan Segura-Aguilar
FRONTIERS IN NEUROSCIENCE (2019)
Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension
Risa Isonaka et al.
HYPERTENSION (2019)
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Daniel A. Monti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Impaired dopamine metabolism in Parkinson's disease pathogenesis
Anna Masato et al.
MOLECULAR NEURODEGENERATION (2019)
Pure Autonomic Failure
Elizabeth A. Coon et al.
MAYO CLINIC PROCEEDINGS (2019)
5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease
Isidro Badillo-Ramirez et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
The heart of PD: Lewy body diseases as neurocardiologic disorders
David S. Goldstein et al.
BRAIN RESEARCH (2019)
The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration
Danielle E. Mor et al.
MOVEMENT DISORDERS (2019)
Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic
Sandro Huenchuguala et al.
NEUROTOXICITY RESEARCH (2019)
Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases
David S. Goldstein et al.
JCI INSIGHT (2019)
Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein
Jonathan W. Werner-Allen et al.
BIOCHEMISTRY (2018)
Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure
Risa Isonaka et al.
CLINICAL AUTONOMIC RESEARCH (2018)
3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine
Yunden Jinsmaa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study
V. Donadio et al.
SCIENTIFIC REPORTS (2018)
Tuning the Balance between Fibrillation and Oligomerization of α-Synuclein in the Presence of Dopamine
Shivnetra Saha et al.
ACS OMEGA (2018)
Prion Peptides Are Extremely Sensitive to Copper Induced Oxidative Stress
Simone Dell'Acqua et al.
INORGANIC CHEMISTRY (2017)
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
Gabriel Gustafsson et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
Danielle E. Mor et al.
NATURE NEUROSCIENCE (2017)
On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
Juan Segura-Aguilar
NEURAL REGENERATION RESEARCH (2017)
Effects of α-synuclein on axonal transport
Laura A. Volpicelli-Daley
NEUROBIOLOGY OF DISEASE (2017)
N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells
David S. Goldstein et al.
NEUROCHEMICAL RESEARCH (2017)
Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy
David S. Goldstein et al.
PARKINSONISM & RELATED DISORDERS (2017)
TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease
Seong Su Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N. Plotegher et al.
SCIENTIFIC REPORTS (2017)
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease
Jenny-Ann Phan et al.
SCIENTIFIC REPORTS (2017)
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial
Agnieszka Ciesielska et al.
PLOS ONE (2017)
Superoxide is the critical driver of DOPAL autoxidation, lysyl adduct formation, and crosslinking of α-synuclein
Jon W. Werner-Allen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Pure autonomic failure without synucleinopathy
Risa Isonaka et al.
CLINICAL AUTONOMIC RESEARCH (2017)
Is pure autonomic failure a distinct nosologic entity?
Risa Isonaka et al.
CLINICAL AUTONOMIC RESEARCH (2017)
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
Andrea Herrera et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Natural history of pure autonomic failure: A United States prospective cohort
Horacio Kaufmann et al.
ANNALS OF NEUROLOGY (2017)
Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study
Zhen-Nian Zhang et al.
BRAIN RESEARCH (2017)
Skin nerve misfolded -synuclein in pure autonomic failure and Parkinson disease
Vincenzo Donadio et al.
ANNALS OF NEUROLOGY (2016)
Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
Jon W. Werner-Allen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
Emma Deas et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite
David G. Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease
Edna Gruenblatt et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells
David S. Goldstein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity
Kelly M. Lohr et al.
ACS CHEMICAL NEUROSCIENCE (2015)
The Sympathetic Nervous System Alterations in Human Hypertension
Guido Grassi et al.
CIRCULATION RESEARCH (2015)
Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
Ching-Chi Chiu et al.
EXPERIMENTAL NEUROLOGY (2015)
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
Cristian Follmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease
Makoto Takahashi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy
David S. Goldstein et al.
PARKINSONISM & RELATED DISORDERS (2015)
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration
David S. Goldstein et al.
PARKINSONISM & RELATED DISORDERS (2015)
DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity
Patricia Munoz et al.
TOXICOLOGICAL SCIENCES (2015)
Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain
Joanna S. Fowler et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease
John E. Casida et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
Guoxiang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum
Christian Pifl et al.
JOURNAL OF NEUROSCIENCE (2014)
Multiple Organ Involvement by Alpha-Synuclein Pathology in Lewy Body Disorders
Ellen Gelpi et al.
MOVEMENT DISORDERS (2014)
Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus
Tonya N. Taylor et al.
NEUROPHARMACOLOGY (2014)
Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein
Yunden Jinsmaa et al.
NEUROSCIENCE LETTERS (2014)
TARGETING ALDEHYDE DEHYDROGENASE 2: NEW THERAPEUTIC OPPORTUNITIES
Che-Hong Chen et al.
PHYSIOLOGICAL REVIEWS (2014)
Cardiac sympathetic denervation without Lewy bodies in a case of multiple system atrophy
G. A. Cook et al.
PARKINSONISM & RELATED DISORDERS (2014)
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders
David S. Goldstein et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
Kelly M. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease
Huaibin Cai et al.
TRANSLATIONAL NEURODEGENERATION (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies
Marco Bisaglia et al.
FASEB JOURNAL (2013)
Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse
Rita Perfeito et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Skin sympathetic fiber α-synuclein deposits A potential biomarker for pure autonomic failure
Vincenzo Donadio et al.
NEUROLOGY (2013)
INCREASED VULNERABILITY OF PARKIN KNOCK DOWN PC12 CELLS TO HYDROGEN PEROXIDE TOXICITY: THE ROLE OF SALSOLINOL AND NM-SALSOLINOL
Yang Su et al.
NEUROSCIENCE (2013)
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
Arthur G. Fitzmaurice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity
Meret Nora Gaugler et al.
ACTA NEUROPATHOLOGICA (2012)
Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity
Patricia Munoz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity
Lydia M. M. Vermeer et al.
BRAIN RESEARCH (2012)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
Lewy pathology and neurodegeneration in premotor Parkinson's disease
Kelly Del Tredici et al.
MOVEMENT DISORDERS (2012)
Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
Margaret Chia-Ying Wey et al.
PLOS ONE (2012)
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Dalton James Surmeier et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities
Alpa H. Gautam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease
Sirsendu Jana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Catechols in post-mortem brain of patients with Parkinson disease
D. S. Goldstein et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
He-Jin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone
David G. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases
David S. Goldstein et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
DOPAMINE OXIDATION FACILITATES ROTENONE-DEPENDENT POTENTIATION OF N-METHYL-D-ASPARTATE CURRENTS IN RAT SUBSTANTIA NIGRA DOPAMINE NEURONS
Y. -N. Wu et al.
NEUROSCIENCE (2011)
Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
Lydia M. Mexas et al.
NEUROTOXICOLOGY (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Neurotoxic Effects of Tetrahydroisoquinolines and Underlying Mechanisms
Young-Joon Surh et al.
Experimental Neurobiology (2011)
α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
Marco Bisaglia et al.
BMC NEUROSCIENCE (2010)
α-SYNUCLEIN ACCUMULATION IN SKIN NERVE FIBERS REVEALED BY SKIN BIOPSY IN PURE AUTONOMIC FAILURE
T. Shishido et al.
NEUROLOGY (2010)
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
W. Michael Panneton et al.
PLOS ONE (2010)
Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study
Estifanos Ghebremedhin et al.
ACTA NEUROPATHOLOGICA (2009)
Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive Intermediate
Yunden Jinsmaa et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease
Teresa G. Hastings
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner
Chi L. L. Pham et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
Tonya N. Taylor et al.
JOURNAL OF NEUROSCIENCE (2009)
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Thomas S. Guillot et al.
MOLECULAR NEUROBIOLOGY (2009)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
Modulation of α-Synuclein Aggregation by Dopamine: A Review
Su Ling Leong et al.
NEUROCHEMICAL RESEARCH (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
Molecular and Neurochemical Mechanisms in PD Pathogenesis
Irmgard Paris et al.
NEUROTOXICITY RESEARCH (2009)
Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress
Andrew J. Linsenbardt et al.
NEUROTOXICOLOGY (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease
Dennis W. Dickson et al.
ACTA NEUROPATHOLOGICA (2008)
Incidental Lewy body disease and preclinical Parkinson disease
Anthony DelleDonne et al.
ARCHIVES OF NEUROLOGY (2008)
Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinsons disease
Satoshi Orimo et al.
BRAIN (2008)
Central dopamine deficiency in pure autonomic failure
David S. Goldstein et al.
CLINICAL AUTONOMIC RESEARCH (2008)
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease
Ming-Kai Chen et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Linan Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
Hiroshige Fujishiro et al.
MOVEMENT DISORDERS (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells
Jun Tang Guo et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α-synuclein
Soon S. Park et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: The role of aldehyde dehydrogenase
Satori A. Marchitti et al.
PHARMACOLOGICAL REVIEWS (2007)
Kinetic and structural analysis of the early oxidation products of dopamine -: Analysis of the interactions with α-synuclein
Marco Bisaglia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of aldehyde detoxification in CNS mitochondria by fungicides
Laura J. Leiphon et al.
NEUROTOXICOLOGY (2007)
Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy
Satoshi Orimo et al.
ACTA NEUROPATHOLOGICA (2007)
Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Roya Tehranian et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2006)
α-synuclein overexpression increases cytosolic catecholamine concentration
Eugene V. Mosharov et al.
JOURNAL OF NEUROSCIENCE (2006)
α-Synuclein facilitates the toxicity of oxidized catechol metabolites:: Implications for selective neurodegeneration in Parkinson's disease
T Hasegawa et al.
FEBS LETTERS (2006)
Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra
S Yamamoto et al.
NEUROSCIENCE LETTERS (2006)
Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease:: Comparison between dementia with Lewy bodies and Parkinson's disease
M Suzuki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: Implications for Parkinson's disease
FH Khan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells
AA Dukes et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy
H Matsui et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2005)
Profound cardiac sympathetic denervation occurs in Parkinson disease
T Amino et al.
BRAIN PATHOLOGY (2005)
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases
WJ Burke et al.
NEUROTOXICOLOGY (2004)
Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons
W Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Autonomic dysfunction in dementia with Lewy bodies
P Thaisetthawatkul et al.
NEUROLOGY (2004)
3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis
WJ Burke et al.
BRAIN RESEARCH (2003)
Brainstem in multiple system atrophy: Clinicopathological correlations
EE Benarroch
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension
DS Goldstein et al.
CLINICAL SCIENCE (2003)
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension
DS Goldstein et al.
NEUROLOGY (2003)
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases
C Zarow et al.
ARCHIVES OF NEUROLOGY (2003)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease
M Asanuma et al.
NEUROTOXICITY RESEARCH (2003)
Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line
J Lotharius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Orthostatic hypotension from sympathetic denervation in Parkinson's disease
DS Goldstein et al.
NEUROLOGY (2002)
Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism
MJ Volles et al.
BIOCHEMISTRY (2002)
Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter
A Storch et al.
BIOCHEMICAL PHARMACOLOGY (2002)
3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis
SW Li et al.
MOLECULAR BRAIN RESEARCH (2001)
Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors
P Weingarten et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria
BS Kristal et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Accumulation of alpha-synuclein in autonomic nem es in pure autonomic failure
H Kaufmann et al.
NEUROLOGY (2001)
Pure autonomic failure in association with human α-synucleinopathy
K Arai et al.
NEUROSCIENCE LETTERS (2000)
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
I Lamensdorf et al.
BRAIN RESEARCH (2000)
Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific
J Taki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
分享论文
